NEW YORK (GenomeWeb News) – Microfluidics firm Dolomite today said it has licensed microdroplet generation technology IP from the Japan Science and Technology Agency.

The deal covers patent families WO2002/068104 and WO2005/089921, and as part of the agreement, Dolomite can sublicense the technology. Licenses are issued on a per-chip basis and are available in any quantity. Dolomite customers can purchase and use Dolomite droplet chips for R&D.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."